Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-10-23 Capital/Financing Update
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2025 ,inter alia, to consider and approve the Unaudited Financial Statements ....
Capital/Financing Update Classification · 95% confidence The document is a notification dated 23rd October 2025 from Sanofi India Limited addressed to stock exchanges (BSE and NSE). It informs about a scheduled Board of Directors meeting on 29th October 2025 to consider and approve unaudited financial statements for the quarter and nine months ended 30th September 2025 and to consider declaring an interim dividend. It also mentions the trading window closure dates. The document is a pre-meeting announcement and does not contain any financial statements or results itself. It is a regulatory disclosure about an upcoming board meeting and related agenda items, consistent with a Capital/Financing Update or Regulatory Filing. However, since it specifically relates to the board meeting scheduling and agenda, it fits best under Capital/Financing Update (CAP) as it relates to financial results approval and dividend declaration. The document length is short and no actual financial data is included, so it is not an Interim Report (IR) or Earnings Release (ER).
2025-10-23 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, addressed to stock exchanges. It includes information about newspaper advertisements related to shareholder notices for re-lodgement of transfer requests of physical shares and an Investor Education and Protection Fund (IEPF) campaign. The content is primarily an announcement of regulatory disclosures and shareholder notices, not a detailed financial report or management discussion. The document length is about 15,000 characters, but the content is an official regulatory disclosure and announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-18 English
Please find enclosed copies of Newspaper Advertisement regarding ongoing special window for re-lodgement of transfer requests of physical shares and 100 Days IEPF Campaign "Saksham Niveshak"
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which is a regulatory requirement for listed companies to inform stock exchanges about material events or information. The content includes notices about shareholder-related activities such as re-lodgement of transfer requests of physical shares and an Investor Education and Protection Fund (IEPF) campaign. It also contains tender notices and other miscellaneous information. There is no detailed financial data, management discussion, or audit information. The document is a formal announcement to stock exchanges and shareholders about ongoing activities and compliance matters, not a full report or detailed financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-18 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an order issued by a tax authority (Assistant Commissioner, CGST & CX Mumbai) regarding an amnesty scheme application and related financial penalties and interest waivers. The document is a notification of a regulatory or compliance event rather than a financial report or detailed analysis. It does not contain financial statements, earnings data, or management discussion. The document length is 3573 characters, which is relatively short and consistent with a regulatory announcement. It is signed by the Company Secretary and Compliance Officer, indicating it is an official regulatory disclosure. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-16 English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an order issued by a tax authority (Assistant Commissioner, CGST & CX Mumbai) regarding an amnesty scheme application and related financial penalties and waivers. The document is a formal notification to stock exchanges about this regulatory order and its financial impact on the company. It does not contain financial statements, earnings data, or detailed management discussion. It is a regulatory announcement about a legal/regulatory matter affecting the company. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the period ended 30th September 2025. It is a confirmation certificate related to dematerialisation of securities and compliance with SEBI regulations. The document is short (3401 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a regulatory filing confirming compliance with specific regulations. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-10-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.